Market Value55,338,000
Total Holdings55
File Date2019-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SRPT / Sarepta Therapeutics, Inc.
GWP / GW Pharmaceuticals plc
AGIO / Agios Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
PCRX / Pacira BioSciences, Inc.
BOLD / Boundless Bio, Inc.
ONCE / Spark Therapeutics, Inc.
INSM / Insmed Incorporated
FOLD / Amicus Therapeutics, Inc.
GBT / Global Blood Therapeutics Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
/ Immunomedics, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
SGEN / Seagen Inc
ALNY / Alnylam Pharmaceuticals, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
VKTX / Viking Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
ALKS / Alkermes plc
BHVN / Biohaven Ltd.
FBIO / Fortress Biotech, Inc.
GTHX / G1 Therapeutics, Inc.
CRSP / CRISPR Therapeutics AG
EPZM / Epizyme Inc
QURE / uniQure N.V.
LGND / Ligand Pharmaceuticals Incorporated
IBB / iShares Trust - iShares Biotechnology ETF
IBB / iShares Trust - iShares Biotechnology ETF Call
FGEN / FibroGen, Inc.
BMRN / BioMarin Pharmaceutical Inc.
IONS / Ionis Pharmaceuticals, Inc.
NKTR / Nektar Therapeutics
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
INCY / Incyte Corporation
MGNX / MacroGenics, Inc.
ILMN / Illumina, Inc.
EXAS / Exact Sciences Corporation
REPH / Societal CDMO Inc
QGEN / Qiagen N.V.
MTD / Mettler-Toledo International Inc.
PRQR / ProQR Therapeutics N.V.
CRL / Charles River Laboratories International, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
BPMC / Blueprint Medicines Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BMY / Bristol-Myers Squibb Company
CKPT / Checkpoint Therapeutics, Inc.
IQV / IQVIA Holdings Inc.
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
EXEL / Exelixis, Inc.
CELG / Celgene Corp.
TECH / Bio-Techne Corporation
BIIB / Biogen Inc.
ARNA / Arena Pharmaceuticals Inc
ZGNX / Zogenix Inc
NBIX / Neurocrine Biosciences, Inc.
GILD / Gilead Sciences, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
NTLA / Intellia Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
ICPT / Intercept Pharmaceuticals Inc
UTHR / United Therapeutics Corporation
AMGN / Amgen Inc.